We validated previous preclinical data that HDAC inhibition favorably modulates the PDA TME, creating a less immunosuppressive milieu, including altering TAM populations, favoring Th1-like phenotypes, fomenting maturation of DCs, and increasing activation and proliferation of memory T cells in the periphery. Here, HDAC9 is linked to Patent ductus arteriosus.